Japan urges build-up of data
This article was originally published in Clinica
Japan's new medical devices master file system, a raw material registration database, needs more support from companies to make it work. The system allows product applicants to refer to already registered data as a means of abbreviating their product applications, and thereby shorten the time it takes to get products onto the market.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.